Native-like cyclic peptide models of a viral antigenic site: Finding a balance between rigidity and flexibility

Journal of Molecular Recognition

Volumn 13, Issue 1, 2000, Pages 5-13

  Valero, Mari Luz ^a   Camarero, Julio A ^a,b   Haack, Thomas ^a,c   Mateu, Mauricio G ^d   Domingo, Esteban ^d   Giralt, Ernest ^a   Andreu, David ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b ROCKEFELLER UNIVERSITY   (United States)

^c Menarini Ricerche SpA   (Italy)

^d CENTRO DE BIOLOGÍA MOLECULAR SEVERO OCHOA   (Spain)

Author keywords

Antigenic site A; Conformational stability; Cyclic disulfide peptide; Epitope mimics; Foot and mouth disease virus

Indexed keywords

ANTIGEN DETECTION; ANTIGEN SPECIFICITY; CIRCULAR DICHROISM SPECTROSCOPY; CRYSTALLOGRAPHY; CYCLIZATION; DISULFIDE BOND; ENVELOPE PROTEIN; FOOT AND MOUTH DISEASE VIRUS C; MONOCLONAL ANTIBODY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PEPTIDE ANALYSIS; PROTEIN CONFORMATION; PROTEIN STABILITY; VIRUS ANTIGEN;

FOOT-AND-MOUTH DISEASE VIRUS; FOOT-AND-MOUTH DISEASE VIRUS C;

EID: 0034013532     PISSN: 09523499     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1352(200001/02)13:1<5::AID-JMR480>3.0.CO;2-L     Document Type: Article

References (51)

1. Acharya R, Fry E, Stuart D, Fox G, Rowlands DJ, Brown F. 1989. The three-dimensional structure of foot-and-mouth disease virus at 2.9 Å resolution. Nature 337: 709-716.
2. Adeva A, Camarero JA, Giralt E, Andreu D. 1995. Boc-S-methylbenzyl-(S)-2-amino-6-mercaptohexanoic acid: preparation and application to the synthesis of a large cyclic disulfide peptide. Tetrahedron Lett. 36: 3885-3888.
3. Andreu D, Albericio F, Solé NA, Munson MC, Ferrer M, Barany G. 1994. Formation of disulfide bonds in synthetic peptides and proteins. Meth. Mol. Biol. 35: 91-169.
4. Andreu D, Camarero JA, Valero ML, Roig X, Haack T, Giralt E, Verdaguer N, Fita I, Mateu MG, Domingo E. 1996. Synthetic, structural and immunochemical approaches to antigen-antibody interaction in foot-and-mouth disease virus. In Peptides: Chemistry, Structure and Biology. Proceedings of the Fourteenth American Peptide Symposium, Kaumaya PTP, Hodges RS, (eds). Mayflower Scientific: Kingswinford; 875-877.
5. Bachrach, HL. 1968. Foot-and-mouth disease. A. Rev. Microbiol. 22: 201-244.
6. Bachrach HL, Moore DM, McKercher PD, Polatnik J. 1975. Immune and antibody responses to an isolated capsid protein of foot-and-mouth disease virus. J. Immunol. 115: 1636-1641.
7. Barany G, Merrifield RB. 1979. Solid phase peptide synthesis. In The Peptides, vol. 2 (ed. E Gross and J Meienhofer), pp. 1-284. Academic Press, New York.
8. Barany G, Albericio F, Solé NA, Griffin GW, Kates SA, Hudson D. 1992. Novel polyethylene glycol-polystyrene (PEG-PS) graft supports for solid phase peptide synthesis. In Peptides 1992: Proceedings of the Twenty-second European Peptide Symposium, Schneider CH and Eberle AN (eds), Escom, Leiden; pp. 267-268.
9. 3) inhibit binding and infection of foot-and-mouth disease virus to culture cells. J. Gen. Virol. 69: 2664-2666.
10. Bernatowicz MS, Daniels SB, Köster H. 1989. A comparison of acid-labile linkage agents for the synthesis of peptide C-terminal amides. Tetrahedron Lett. 30: 4645-4648.
11. Bittle JL, Houghten RA, Alexander H, Sutcliffe JG, Lerner RA, Rowlands DJ, Brown F. 1982. Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature 298: 30-33.
12. Bothner-By AA, Stephens RL, Lee JM, Warren CD, Jeanloz RW. 1984. Structure determination of a tetrasaccharide: transient nuclear Overhauser effects in the rotating frame. J. Am. Chem. Soc. 106: 811-813.
13. Brown F. 1992. New approaches to vaccination against foot-and-mouth disease. Vaccine 10: 1022-1026.
14. Camarero JA, Andreu D, Cairó JJ, Mateu MG, Domingo E, Giralt E. 1993. Cyclic disulfide model of the major antigenic site of serotype C foot-and-mouth disease virus. FEBS Lett. 328: 159-164.
15. Carreño C, Roig X, Cairó JJ, Camarero JA, Mateu MG, Domingo E, Giralt E, Andreu D. 1992. Studies on antigenic variability of C-strains of foot-and-mouth disease virus by means of synthetic peptides and monoclonal antibodies. Int. J. Peptide Protein Res. 39: 41-47.
16. Chen YH, Yang JT, Chan KH. 1974. Determination of the helix and form of proteins in aqueous solution by circular dichroism. Biochemistry 23: 3350-3359.
17. Di Marchi R, Brooke G, Gale C, Cracknell V, Doel T, Mowat N. 1986. Protection of cattle agains foot-and-mouth disease by a synthetic peptide. Science 232: 639-641.
18. Erickson BW, Merrifield RB. 1973. Acid stability of several benzylic protecting groups used in solid phase peptide synthesis. Rearrangement of O-benzyltyrosine to 3-benzyltyrosine. J. Am. Chem. Soc. 95: 3750-3756.
19. Fields GB, Tian Z, Barany G. 1992. Principles and practice of solid phase peptide synthesis. In Synthetic Peptides: a User's Guide, Grant GA (ed.). Freeman, New York; pp. 77-183.
20. Fox G, Parry N, Barnett PV, McGinn B, Rowlands DJ, Brown F. 1989. The cell attachment site on FMDV includes the amino acid sequence RGD. J. Gen. Virol. 70: 625-637.
21. Geourjon C, Deléage G, Roux B. 1991. Antheprot: an interactive graphic software for analyzing protein structures from sequences. J. Mol. Graph. 9: 188-190.
22. Haack T, Camarero JA, Roig X, Mateu MG, Domingo E, Andreu D, Giralt E. 1997. A cyclic disulfide peptide reproduces in solution the main structural features of a native antigenic site of foot-and-mouth disease virus. Int. J. Biol. Macromol. 20: 209-219.
23. Heeb NB, Aberle A, Nambiar KP. 1994. Synthesis of enantiomerically pure N-Fmoc-S-Mob-(S-α-amino-∈-mercaptohexanoic acid and its use in solid phase peptide synthesis. Tetrahedron Lett. 35: 2287-2290.
24. Joisson C, Kuster F, Plaué S, Van Regenmortel MHV. 1993. Antigenic analysis of bean pod mottle virus using linear and cyclized synthetic peptides. Arch. Virol. 128: 299-317.
25. Karlsson R, Michaelsson A, Matsson LJ. 1991. Kinetic analysis of monoclonal antibody-antigen interactions with a new biosensor-based analytical system. J. Immunol. Meth. 145: 229-240.
26. Lea S, Hernández J, Blakemore W, Brocchi E, Curry S, Domingo E, Fry E, Ghazaleh RA, King A, Newman J, Stuart D, Mateu MG. 1994. The structure and antigenicity of a type-C foot-and-mouth disease virus. Structure 2: 123-139.
27. 1 and a laboratory antigenic variant, G67. Structure 3: 571-588.
28. Löfås S, Johnsson B. 1990. A novel hydrogen matrix on gold surfaces in surface plasmon resonance sensors for fast and efficient covalent immobilization of ligands. J. Chem. Soc. Chem. Commun. 21: 1526-1528.
29. Logan D, Abu-Ghazaleh R, Blakemore W, Curry S, Jackson T, King A, Lea S, Lewis R, Newman J, Parry N, Rowlands D, Stuart D, Fry E. 1993. Structure of a major immunogenic site of foot-and-mouth disease virus. Nature 362: 566-568.
30. Mateu MG, Andreu D, Domingo E. 1995a. Antibodies raised in a natural host and monoclonal antibodies recognize similar antigenic features of foot-and-mouth disease virus. Virology 210: 120-127.
31. Mateu MG, Camarero JA, Andreu D, Giralt E, Domingo E. 1995b. Direct evaluation of the immunodominance of a major antigenic site of foot-and-mouth disease virus in a natural host. Virology 206: 298-306.
32. Mateu MG, Rocha E, Vicente O, Vayreda F, Navalpotro C, Andreu D, Pedroso E, Giralt E, Enjuanes L, Domingo E. 1987. Reactivity with monoclonal antibodies of viruses from an episode of foot-and-mouth disease. Virus Res. 8: 261-274.
33. Mateu MG, Martínez MA, Rocha E, Andreu D, Parejo J, Giralt E, Sobrino F, Domingo E. 1989. Implications of a quasispecies genome structure: effect of frequent naturally occurring amino acid substitutions on the antigenicity of foot-and-mouth disease virus. Proc. Natl. Acad. Sci. USA 86: 5883-5887.
34. Mateu MG, Martínez MA, Capucci L, Andreu D, Giralt E, Sobrino F, Brocchi E, Domingo E. 1990. A single amino acid substitution affects multiple overlapping epitopes in the major antigenic site of foot-and-mouth disease virus. J. Gen. Virol. 71: 629-637.
35. McCullough KC, De Simone F, Brocchi E, Capucci L, Crowther JR, Kihm O. 1992. Protective immune response against foot-and-mouth disease. J. Virol. 66: 1835-1840.
36. Muller S, Plaué S, Samama JP, Valette M, Briand JP, Van Regenmortel MHV. 1990. Antigenic properties and protective capacity of a cyclic peptide corresponding to site A of influenza virus haemagglutinin. Vaccine 8: 308-314.
37. Novella IS, Borrego B, Mateu MG, Domingo E, Giralt E, Andreu D. 1993. Use of substituted and tandem-repeated peptides to probe the relevance of the highly conserved RGD tripeptide in the immune response against foot-and-mouth disease virus. FEBS Lett. 330: 253-259.
38. Pereira HG. 1977. Subtyping of foot-and-mouth disease virus. In: Developments in Biological Standardization, vol. 35. Mackowiak C and Regamey RH (eds). Karger, Basel; pp. 167-174.
39. Pereira HG. 1981. Foot-and-mouth disease. In Virus Diseases of Food Animals, vol. 2. Gibbs EPJ (ed.). Academic Press, New York; pp. 333-363.
40. Pfaff E, Mussgay M, Böhm HO, Schultz GE, Schaller H. 1982. Antibodies against a preselected peptide recognize and neutralize foot-and-mouth disease virus. EMBO J. 1: 869-874.
41. Richalet-Secordel PM, Zeder-Lutz G, Plaué S, Sommermeyer-Leroux G, Van Regenmortel MHV. 1994a. Cross-reactivity of monoclonal antibodies to a chimeric V3 peptide of HIV-1 with peptide analogues studied by biosensor technique and ELISA. J. Immunol. Meth. 176: 221-234.
42. Richalet-Secordel PM, Deslandres A, Plaué S, You B, Barré-Sinoussi, Van Regenmortel MHV. 1994b. Cross-reactive potential of rabbit antibodies raised against a cyclic peptide representing a chimeric V3 loop of HIV-1 gp120 studied by biosensor technique and ELISA. FEMS Immunol. Med. Microbiol. 9: 77-88.
43. Schuck P, Minton AP. 1996. Analysis of mass transport-limited binding kinetics in evanescent wave biosensors. Anal. Biochem. 240: 262-272.
44. Schulze-Gahmen U, Klenk HD, Beyreuther K. 1986. Immunogenicity of loop-structured short synthetic peptides mimicking the antigenic site A of influenza virus haemagglutinin. Eur. J. Biochem. 159: 283-289.
45. Strohmaier K, Franze R, Adam KH. 1982. Location and characterization of the antigenic portion of the FMDV immunizing protein. J. Gen. Virol. 59: 295-306.
46. Sutcliffe JG, Shinnick TM, Green N, Lerner R. 1983. Antibodies that react with predeterminated sites on proteins. Science 219: 660-666.
47. Valero M-L, Giralt E, Andreu D. 1999. A comparative study of cyclization strategies applied to the synthesis of head-to-tail cyclic analogs of a viral epitope. J. Pept. Res. 53: 56-67.
48. Van der Werf S, Briand JP, Plaué S, Burckard J, Girard M, Van Regenmortel MHV. 1994. Ability of linear and cyclic peptides of neutralization antigenic site 1 of poliovirus type 1 to induce virus cross-reactive and neutralizing antibodies. Res. Virol. 145: 349-359.
49. Verdaguer N, Mateu MG, Andreu D, Giralt E, Domingo E, Fita I, 1995. Structure of the major antigenic loop of foot-and-mouth disease virus complexed with a neutralizing antibody: Direct involvement of the Arg-Gly-Asp motif in the interaction. EMBO J. 14: 1690-1696.
50. Verdaguer N, Sevilla N, Valero ML, Stuart D, Brocchi E, Andreu D, Giralt E, Domingo E, Mateu MG, Fita I. 1998. A similar pattern of interaction for different antibodies with a major antigenic site of foot-and-mouth disease virus: implications for intratypic antigenic variation. J. Virol. 72: 739-748.
51. Williams WV, Kieber-Emmons T, Von Feldt J, Greene MI, Weiner DB. 1991. Design of bioactive peptides based on antibody hypervariable region structures. Development of conformationally constrained and dimeric peptides with enhanced affinity. J. Biol. Chem. 266: 5182-5190.